Angewandte Chemie International Edition · 2016 · 99 citations · 25 references
PharmacyMedicinal ChemistryOncologyMolecular OncologyOrganometallic ChemistryStructural BiologyCancer NanomedicineG-quadruplex ChemistryLigand BindingMacromolecular AssemblyAnticancer ActivityAnticancer ChemotherapyG-quadruplex Ligand BindingG-quadruplex StructureOrganometallic Anticancer AgentsOrganometallic ComplexesSelective Binding SitesStacking In G-quadruplexes
The dicarbene gold(I) complex [Au(9-methylcaffein-8-ylidene)2 ]BF4 is an exceptional organometallic compound of profound interest as a prospective anticancer agent. This gold(I) complex was previously reported to be highly cytotoxic toward various cancer cell lines in vitro and behaves as a selective G-quadruplex stabilizer. Interactions of the gold complex with various telomeric DNA models have been analyzed by a combined ESI MS and X-ray diffraction (XRD) approach. ESI MS measurements confirmed formation of stable adducts between the intact gold(I) complex and Tel 23 DNA sequence. The crystal structure of the adduct formed between [Au(9-methylcaffein-8-ylidene)2 ](+) and Tel 23 DNA G-quadruplex was solved. Tel 23 maintains a characteristic propeller conformation while binding three gold(I) dicarbene moieties at two distinct sites. Stacking interactions appear to drive noncovalent binding of the gold(I) complex. The structural basis for tight gold(I) complex/G-quadruplex recognition and its selectivity are described.
25
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Röder, Melanie J. Thomson · Drugs in R&D · 2015 · 499 citations · Full text